Chronic pain in children is associated with significant negative impact on social, emotional, and school functioning. Previous studies on the impact of pain on children's functioning have primarily used mixed samples of pain conditions or single pain conditions (eg, headache and abdominal pain) with relatively small sample sizes. As a result, the similarities and differences in the impact of pain in subgroups of children with chronic pain have not been closely examined.
C hronic pain in children and adolescents is a significant public health problem with over 25% of school-age children reporting recurrent or chronic pain. 1 The impact of chronic pain on social and emotional functioning has been studied in various pediatric pain conditions. [2] [3] [4] [5] [6] [7] [8] [9] [10] Results from these studies suggest lower overall functioning in children and adolescents with chronic pain conditions when compared with their healthy counterparts but less is known about how children with various chronic pain syndromes differ from one another.
Most of the aforementioned research studies examining the impact of pediatric pain have focused on either combined samples of various pain conditions or on single conditions in isolation such as abdominal pain, fibromyalgia, or headache. Research on combined pain conditions is limited by relatively small sample sizes for each pain subtype. Similarly, functioning examined in a single pain condition may not generalize to other pain syndromes; therefore, little is known about the potential similarities and differences between various pediatric chronic pain conditions in terms of social and emotional functioning. Results from a recent study suggested that children and adolescents with recurrent headache may have lower levels of disability and depressive symptoms compared with those with widespread musculoskeletal pain. 11 However, a limitation of the study was that classification of pain subtypes was designated based on primary pain location only and not based on clear medical diagnoses based on specific diagnostic criteria.
Despite the relative paucity of research on subgroups of pediatric pain conditions, clinicians anecdotally report distinct differences in patients with various chronic pain syndromes such as greater impairment in those with widespread musculoskeletal pain compared with other pain conditions. It is plausible that chronic pain may have differential impact depending on underlying pathophysiology, specific pain characteristics such as pain location, frequency, and severity, or presence of comorbid somatic symptoms or mood difficulties. The reasons why different pain conditions may result in greater or lesser impact on children's daily lives is as yet poorly understood, yet this topic has important implications for treatment planning. As an initial step, more empirical work is needed to identify areas of commonalities and differences between pain conditions in children, even as science into the underlying biological mechanisms of chronic pain and associated symptoms advances our understanding of specific pain conditions. Juvenile fibromyalgia (JFM) and pediatric chronic migraine (CM) are 2 chronic pain syndromes that have several common elements including persistent or recurrent pain that occurs daily or almost daily. Research on adults has shown that fibromyalgia and migraine headaches share some overlapping features [12] [13] [14] including similar neurobiological changes associated with pain hypersensitivity. 15, 16 However, adult fibromyalgia patients experience poorer quality of life (QOL) compared with those with migraine headaches. 14 Similar to adult fibromyalgia, JFM in children is characterized by constant widespread pain, fatigue, and sleep disturbance, along with multiple associated somatic symptoms. JFM patients also seem to have substantially higher rates of anxiety and mood disturbances 17 than children with CM, 18 but there are no studies comparing QOL differences in the 2 conditions. Treatment regimens for both chronic pain conditions typically consists of medication management and often recommendations for nondrug interventions (eg, cognitivebehavioral therapy and lifestyle changes) to promote selfmanagement and coping. A greater understanding of the impact of these pain subtypes would help inform more tailored approaches specific to their needs.
As part of the screening procedure for 2 ongoing clinical research studies, we obtained extensive information about pain characteristics, QOL, and emotional functioning for over 300 patients who met diagnostic criteria for pediatric CM or JFM. The objective of the current study was to compare pain characteristics, QOL, and emotional functioning (depressive and anxiety symptoms) between patients with CM and those with JFM from the combined samples from these relatively large pediatric studies. On the basis of the prior findings, we expected the CM and JFM groups to be similar in terms of pain intensity. However, we hypothesized that QOL and emotional functioning would be significantly poorer in children and adolescents diagnosed with JFM as compared with those with CM. 11 
MATERIALS AND METHODS

Participants
Participants in the study were pediatric pain patients (age range, 10 to 18 y) diagnosed with JFM or CM and recruited from subspecialty clinics (4 pediatric rheumatology clinics in the Midwestern United States and a single pediatric Headache Center at a children's hospital for the JFM and CM studies, respectively). Participants with JFM were diagnosed by a pediatric rheumatologist based on the 1985 Yunus and Masi criteria 19 for JFM classification (generalized musculoskeletal pain in at least 3 sites for at least 3 mo; Z5 painful tender points upon palpation; associated symptoms such as sleep disturbance, fatigue, headaches, and irritable bowel syndrome). Participants with JFM were excluded if they were diagnosed with another underlying chronic pediatric disease, such as juvenile arthritis or lupus. Participants with CM were diagnosed by a pediatric neurologist board certified in headache medicine using the International Classification of Headache Disorders-2nd Edition definition of migraine (modified for pediatric use), 20 including unilateral or bilateral headaches of 1 to 72 hours duration, nausea and/or vomiting, and 2 of 5 associated symptoms (photophobia, phonophobia, difficulty thinking, or lightheadedness). At least 15 headaches per month were required for a classification of CM and this was confirmed by a prospective 4-week daily headache diary completed by participants. 21 Patients with CM diagnosed with medication overuse or other primary pain syndromes (including JFM) were excluded from the CM group. Participants with known developmental delays were not included in either sample.
Procedure
Participants were identified and introduced to the study by their study physician. If interested in learning more about the study, a research coordinator contacted families to give them detailed information and request their participation. Eligible participants and parents provided written informed consent before the initiation of any study procedures. Institutional Review Board approvals were obtained from all participating study sites.
Measures
Demographic Information
Families were asked to complete forms detailing background and demographic information including race, ethnicity, age, sex, and socioeconomic status.
Pain Characteristics
Participants completed daily pain diaries and returned diaries at their study visit. On the basis of the 2 separate study protocols for JFM and CM, participants with JFM completed 0 to 10 cm daily Visual Analog Scales to assess pain intensity over 1 week, and participants with CM completed daily 0 to 10 Numeric Pain Rating Scales for 4 weeks (28 d). The longer duration of diary completion for patients with CM was required to confirm headache frequency of Z15 headaches per month, in addition to assessing average pain intensity. For the purposes of this study, average pain intensity was defined as average pain over 7 days (for the CM group, this was the average pain intensity of headaches they experienced in the last 7 d of their 4-wk diary). The Visual Analog Scales and numeric pain ratings are reliable, valid instruments used to measure pain in both adult and pediatric populations 22 and provide comparable information. 23, 24 For patients with CM, headache frequency and average duration of pain was also calculated from diaries.
QOL
Pediatric Quality of Life Inventory (PedsQL)-Generic Core Scales: The PedsQL-Generic Version is an instrument commonly used to assess overall QOL in children and adolescents with chronic health conditions, such as cancer, diabetes, rheumatoid arthritis, and headache. 6 Each item has 4 response options: never, sometimes, often, and always. Self-report and parent-proxy versions of the PedsQL were administered. Participants were asked to rate their own (or their child's) QOL in the 4 domains of physical, social, emotional, and school functioning over the last month. The PedsQL is reverse scored with scores ranging from 0 to 100, with higher scores indicative of better functioning. 25 Scores on the PedsQL scales range from about 78 to 91 (for child and parent-proxy report) among healthy children. 26 
Emotional Adjustment and Depression
Children's Depression Inventory (CDI): The CDI is a 27-item self-report measure that assesses cognitive, behavioral, and affective symptoms of depression in children and adolescents. 27 Each question has 3 response choices related to the individual's feelings during the past 2 weeks. Total scores range from 0 to 54 and normative scores based on age and sex are available. CDI total raw scores >10 indicate at least mild depression.
Adolescent Symptom Inventory-4 (ASI-4)-Generalized Anxiety Subscale: The ASI-4 is an instrument used to measure caregiver ratings of a child's emotional functioning. The Generalized Anxiety Subscale of the ASI-4 consists of 8 questions, which ask parents to rate how often their child displays a symptom (never, sometimes, often, or always). Items are then scored either 0 or 1 (0,never and sometimes; 1,often and always) to get a symptom criterion score. Scores of Z5 on the Generalized Anxiety Subscale of the ASI is an indication that the participant exhibits significant symptoms consistent with Generalized Anxiety. 28 
Statistical Analysis
First, descriptive data were computed for all demographic variables and measures of pain, QOL, anxiety, and depression. Pearson correlations between measures of pain, QOL, and emotional functioning were calculated for each group independently to examine relationships between these variables within each illness group. Because of the multiple correlations, we used a more conservative level of significance (P < 0.01) to interpret correlations. A 1-way multivariate analysis of covariance (MANCOVA) with age and sex as covariates, was conducted to test the primary aim, that is, to determine if there were significant differences between the JFM and CM groups based on parent and self-report QOL and emotional functioning (ie, anxiety and depressive symptoms). A Bonferroni correction (0.05Â10 comparisons = 0.005) was used to interpret results of the individual comparisons between groups in the MANCOVA.
In exploratory analyses, we undertook a closer examination of the link between elevated distress and longer pain duration on QOL by assessing whether subgroups of CM patients with higher levels of depressive symptoms and those with constant/nearly constant pain (ie, those that presented most similarly to the JFM group) had QOL scores that were as low as the JFM group. First, the proportion of CM patients versus JFM patients who showed at least mild elevations in depressive symptoms (CDI score >10, Kovacs and colleagues 27 ) was calculated and QOL scores for this "elevated distress" subgroup of CM patients were computed; and second, the proportion of CM patients who had constant (24 h/d) or nearly constant (> 10 h/d) pain was calculated and QOL scores for this "high pain duration" subgroup of CM patients were computed. Although formal statistical analyses were not conducted because of power issues (relatively small number of CM patients in the elevated distress and constant daily pain groups), descriptive data on QOL was compared with the JFM group and the overall CM sample.
RESULTS
Demographic Information
A total of 310 individuals were eligible and of these, 304 were included (JFM = 151, CM = 153) with a mean age of 15.07 and 14.54 years, respectively. One individual with JFM and 5 with CM were excluded from the final sample because of missing data. The majority of the participants were female (JFM, 90.1%; CM, 81.7%) and over 80% of the combined sample was white. The median income for the sample was over $50,000. Detailed demographic information is provided in Table 1 . There were no significant differences in race or income level between the 2 groups (P > 0.05); however, participants in the JFM group were significantly older than the CM group (P = 0.015) and the JFM group had a greater proportion of females (P = 0.036).
Pain Characteristics
Average pain intensity reported by youth with CM was 5.48 (SD = 1.88) and for those with JFM was 5.36 (SD = 1.79) and this difference was not statistically significant (t = 0.566, P = 0.572). The average number of migraines per week within the CM group was 5.7 (SD = 1.44) indicating that headaches occurred almost daily, and the average headache duration was 9.94 hours (SD = 8.73).
Correlations Between Parent and Child QOL Reports and Measures of Emotional Functioning
Bivariate correlations between measures were conducted separately for each group (Tables 2 and 3 ). Results indicated that parent-proxy and child reports of QOL were significantly associated with one another (Pearson r ranging from 0.42 to 0.69; P < 0.01) and parent-reported anxiety and self-reported depression were positively correlated for both JFM and CM groups (r = 0.42 and 0.42; P < 0.01, respectively). These results suggest moderate to high agreement between parent and child report on the various domains of functioning. Anxiety and depressive symptoms were significantly negatively correlated with all QOL domains for both groups.
QOL in JFM and CM
Mean scores of both JFM and CM groups were lower than those reported for healthy children 26 with the exception of social functioning, which was not impaired in the CM group. There were, however, significant differences between the 2 pain samples in this study. The omnibus MANCOVA showed significant differences between the 2 groups on the (Table 4 ). In exploratory analysis, it was found that 28.8% of the CM group fell in the "elevated distress" group (CDI score >10) compared with 60.3% of the JFM sample. Descriptive data on child-reported QOL domains for this "elevated distress" CM subgroup showed that they had lower emotional (mean = 55.11; SD = 17.83), social (mean = 79.88; SD = 18.35), and school functioning (mean = 42.27; SD = 16.05) than the overall CM group and these scores were more similar to the JFM group. When duration of pain was considered, the subgroup of CM patients with "high pain duration" (constant/nearly constant pain; 36.6% of the CM sample) had similar QOL scores to the overall CM group (scores ranging from 58.48 to 84.82), which were much higher than the JFM group-indicating that headaches of longer duration did not seem to be associated with lowered QOL.
DISCUSSION
The findings of this study highlight the utility of studying the similarities and differences between pediatric pain subgroups to get a more in-depth understanding of the impact of these pain conditions on QOL. CM and FM are À 0.28** À 0.51** À 0.38** À0.46** À0.39** À0.67** À0.43** À0.63** ASI (range, 0-8)
Anxiety symptoms À 0.42** À 0.54** À 0.28** À0.41** À0.32** À0.35** À0.23** À0.36** 0.42** NPS (range, 0-10) À 0.05 À 0.12 À 0.09 À0.11 À0.10 À0.19 À0.17 À0.28** 0.21 0.04 **Correlation significant at the 0.01 level (2-tailed). ASI indicates Adolescent Symptom Inventory; CDI, Child Depression Inventory; CEF, emotional functioning; CPF, physical functioning; CSCF, school functioning; CSF, social functioning; NPS, Numeric Pain Scale; PEF, emotional functioning; PPF, physical functioning; PSCF, school functioning; PSF, social functioning; VAS, Visual Analog Scale. similar in that they are both characterized by persistent, daily, or almost daily pain. Studies in adults have shown that these condition also have some overlapping features including underlying neurobiological changes associated with pain hypersensitivity. 15, 16 However, the impact of migraines and fibromyalgia on QOL and psychosocial function, particularly in youth, is poorly understood. The marked differences between the CM and JFM groups found in this study highlight how patients with different pain subtypes may present to pediatric care centers with varying psychosocial profiles. As the results suggest, the negative impact on QOL is much less severe for youth with CM than for those with JFM. Despite similar levels of pain intensity in both groups, youth with JFM had markedly poorer physical, emotional, social, and school functioning (per parent and child report) than youth with CM. Even the subgroup of CM patients who had constant or nearly constant pain had higher QOL than JFM patients, suggesting that pain characteristics (intensity or duration) do not directly influence QOL. In contrast, psychological distress seemed to demonstrate a stronger connection with QOL across groups. In general, the JFM group reported markedly greater problems with anxiety and depressive symptoms than CM patients along with poorer QOL in all domains. When a subgroup of the more distressed CM patients were compared with JFM patients on QOL, it was observed that their scores were more similar to JFM patients, supporting a link between emotional functioning and QOL.
It should be noted that although patients with CM seem to have a higher level of functioning in most domains, their functioning at school was reported as being lower than healthy children. Therefore, the impact of headaches on school performance may be an area of specific concern for CM patients. JFM patients also reported very poor school functioning, but this was in the context of poor emotional and physical function as well, which may have slightly different implications from a treatment perspective. Although the underlying reasons for the marked differences in the impact of CM and JFM on QOL are not well understood, the findings provide some guidance into potential avenues for intervention.
Specifically, the results of this study suggest that the clinical care for patients with CM and JFM can be designed to be more appropriate to their specific needs. Offering training in relatively basic pain coping strategies (eg, relaxation, distraction, and pacing techniques) and recommending healthy lifestyle changes (such as more attention to hydration, nutrition, and physical activity) may be helpful for most youth with CM. For difficulties at school, more support and resources might be provided to help them with academic concerns. These strategies may prove insufficient for the management of young patients with JFM who are likely to have more complex needs. Patients with JFM are more likely to experience symptoms of elevated depression and anxiety and they tend to have significantly poorer QOL across multiple domains. Hence, greater attention should be given to the comprehensive assessment of youth with JFM followed by a multidisciplinary treatment plan that is sufficiently intensive to address the physical limitations and psychosocial difficulties experienced by youth with JFM that cut across the domains of emotional, social, and school functioning. In particular, most JFM patients could benefit from a complete course of cognitive-behavioral therapy for pain coping skills training, 29 and for those who have clinically significant depressive symptoms, consideration of antidepressant medication may be necessary as well. JFM patients have also been found to be very sedentary, 30 likely leading to a cycle of inactivity and deconditioning contributing to further pain and impairment. For these patients, increasing physical activity and exercise participation should form an essential component of treatment. Early studies of exercise interventions for JFM patients have been promising 31 although careful attention to designing exercise programs keeping in mind JFM patients' exercise intolerance is needed to maximize their engagement in treatment. 32 This study had several strengths including the relatively large pediatric sample with similar demographic characteristics, with clear diagnoses, and recruitment from similar (tertiary care) treatment settings. However, some limitations of this study include: (1) recruitment from tertiary care settings somewhat limits generalizability of the findings to all health care settings and (2) not being able to examine underlying reasons for the substantial differences in QOL observed between JFM and CM. Further studies might examine the role of emotional distress and the role of associated comorbidities, which are much more salient in JFM. Finally, the focus of this study was limited to 2 of the many pain conditions of childhood. Nevertheless, we believe that the study represents a step toward a more sophisticated understanding of the characteristics and the needs of pediatric pain subpopulations, which have thus far been viewed as a more or less homogenous group from a research perspective. Although it is true that many pediatric pain patients respond well to similar types of treatment approaches, such as cognitive-behavioral therapy, 33 there may be ways to apply resources in a more targeted or tailored manner, and vary the intensity (dose) and comprehensiveness of services based on the particular needs of each of the subgroups. It is hoped that future research with sufficient samples of different pediatric subpopulations will further expand on key differences between pediatric pain subpopulations and examine whether current treatment approaches can be improved to incorporate a more finegrained knowledge of each medical condition.
